Adma Biologics Inc (ADMA)

Cash & Short-Term Investments

$136.02M

Quarterly · Period ending: · USD

ADMA logo

ADMA Cash & Short-Term Investments

Latest reported$136.02M
ADMA Quarterly Cash & Short-Term Investments ($11.25M → $136.02M)
High-resolution chart · PNG

ADMA cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
136,020,000
138,153,000
87,630,000
61,385,000
90,285,000
71,625,000
103,147,000
86,707,000
88,244,000
45,325,000
51,352,000
74,156,765
62,512,889
69,204,163
86,522,000
34,906,020
52,415,053
69,504,946
51,089,118
34,410,570
42,408,958
61,965,709
55,921,152
59,675,045
75,781,122
101,235,699
26,752,135
48,006,152
73,615,909
16,534,278
22,754,852
42,367,489
55,153,975
26,119,837
43,107,574
13,601,391
25,574,009
8,787,928
15,305,051
18,932,666
23,820,136
11,620,110
16,809,136
20,942,128
23,752,194
28,076,404
21,851,705
20,271,154
24,182,609
28,721,000
29,084,661
5,380,043
7,653,479
10,320,517
12,535,672
10,720,397
12,887,788
14,239,828
8,079
5,909
8,512
16,192
3,100
3,619,000
12,012
2,934,000
6,844,000
9,270,000
8,688,000
10,108,000
8,028,000
2,647,000
6,569,000
8,787,000
7,805,000
14,652,000
16,663,000
9,033,000
11,253,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.